Angie Price

1.2k total citations
13 papers, 498 citations indexed

About

Angie Price is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Angie Price has authored 13 papers receiving a total of 498 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 6 papers in Hepatology and 2 papers in Infectious Diseases. Recurrent topics in Angie Price's work include Hepatitis C virus research (6 papers), Hepatitis B Virus Studies (5 papers) and Liver Disease Diagnosis and Treatment (4 papers). Angie Price is often cited by papers focused on Hepatitis C virus research (6 papers), Hepatitis B Virus Studies (5 papers) and Liver Disease Diagnosis and Treatment (4 papers). Angie Price collaborates with scholars based in United States, United Kingdom and Canada. Angie Price's co-authors include R. Todd Stravitz, Velimir A. Luketic, Richard K. Sterling, Arun J. Sanyal, Mitchell L. Shiffman, Shyam Kottilil, Sarah Kattakuzhy, Henry Masur, Rachel Silk and Eleanor Wilson and has published in prestigious journals such as Annals of Internal Medicine, Hepatology and Clinical Infectious Diseases.

In The Last Decade

Angie Price

12 papers receiving 478 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Angie Price United States	8	394	341	69	41	39	13	498
Bita Behnava Iran	15	568 1.4×	533 1.6×	31 0.4×	37 0.9×	37 0.9×	57	644
G. Dultz Germany	14	299 0.8×	301 0.9×	45 0.7×	26 0.6×	61 1.6×	45	519
Marta Wawrzynowicz‐Syczewska Poland	10	225 0.6×	211 0.6×	37 0.5×	13 0.3×	30 0.8×	46	373
Baris Deniz United States	10	249 0.6×	245 0.7×	35 0.5×	18 0.4×	36 0.9×	25	412
C.A. Navascués Spain	14	673 1.7×	615 1.8×	51 0.7×	28 0.7×	72 1.8×	30	849
M. Willems Belgium	11	257 0.7×	215 0.6×	36 0.5×	17 0.4×	42 1.1×	12	354
Fatih Oğuz Önder Türkiye	14	412 1.0×	442 1.3×	28 0.4×	30 0.7×	24 0.6×	39	620
Gidon Ellis United Kingdom	7	207 0.5×	291 0.9×	57 0.8×	9 0.2×	22 0.6×	12	584
I. Lonjon France	8	482 1.2×	495 1.5×	57 0.8×	66 1.6×	46 1.2×	9	622
Carmen Monica Preda Romania	12	231 0.6×	297 0.9×	42 0.6×	9 0.2×	22 0.6×	52	445

Countries citing papers authored by Angie Price

Since Specialization

Citations

This map shows the geographic impact of Angie Price's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angie Price with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angie Price more than expected).

Fields of papers citing papers by Angie Price

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angie Price. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angie Price. The network helps show where Angie Price may publish in the future.

Co-authorship network of co-authors of Angie Price

This figure shows the co-authorship network connecting the top 25 collaborators of Angie Price. A scholar is included among the top collaborators of Angie Price based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angie Price. Angie Price is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Lin, Christine Y., et al.. (2024). RNA Interference Therapeutics for Chronic Hepatitis B: Progress, Challenges, and Future Prospects. Microorganisms. 12(3). 599–599. 18 indexed citations

Price, Angie, Collin A. Hovinga, Thierry Lacaze‐Masmonteil, et al.. (2024). Harmonizing Quality Improvement Metrics Across Global Trial Networks to Advance Paediatric Clinical Trials Delivery. Therapeutic Innovation & Regulatory Science. 58(5). 953–964. 2 indexed citations

Price, Angie, et al.. (2024). Roadmap for the expression of canonical and extended endocannabinoid system receptors and metabolic enzymes in peripheral organs of preclinical animal models. Physiological Reports. 12(4). e15947–e15947. 3 indexed citations

Price, Angie, et al.. (2024). Significant delays exist in industry-sponsored pediatric clinical drug trial start-up and enrollment processes. Contemporary Clinical Trials. 146. 107701–107701.

Price, Angie, et al.. (2022). A Phase 2 open label study of ledipasvir/sofosbuvir for 12 weeks in subjects with hepatitis B virus infection. Journal of Medical Virology. 95(1). e28105–e28105. 4 indexed citations

Wilson, Eleanor, Jennifer Hoffmann, Benjamin Emmanuel, et al.. (2019). A pilot study of safety and efficacy of HCV retreatment with sofosbuvir/velpatasvir/voxilaprevir in patients with or without HIV (RESOLVE STUDY). Journal of Hepatology. 71(3). 498–504. 13 indexed citations

Kattakuzhy, Sarah, Chloe Gross, Benjamin Emmanuel, et al.. (2017). Expansion of Treatment for Hepatitis C Virus Infection by Task Shifting to Community-Based Nonspecialist Providers. Annals of Internal Medicine. 167(5). 311–318. 166 indexed citations

Gross, Chloe, Elizabeth Akoth, Angie Price, et al.. (2016). HIV/HCV Co-infection: Overcoming Barriers to Treatment. Journal of the Association of Nurses in AIDS Care. 27(4). 524–529. 4 indexed citations

Wilson, Eleanor, Sarah Kattakuzhy, Sreetha Sidharthan, et al.. (2015). Successful Retreatment of Chronic HCV Genotype-1 Infection With Ledipasvir and Sofosbuvir After Initial Short Course Therapy With Direct-Acting Antiviral Regimens. Clinical Infectious Diseases. 62(3). 280–288. 38 indexed citations

10.

Yachimski, Patrick, Sachin Wani, Tina Higginbotham, et al.. (2014). Preference of Endoscopic Ablation Over Medical Prevention of Esophageal Adenocarcinoma by Patients With Barrett’s Esophagus. Clinical Gastroenterology and Hepatology. 13(1). 84–90. 8 indexed citations

11.

Shiffman, Mitchell L., Angie Price, Richard K. Sterling, et al.. (2007). Treatment of chronic hepatitis C virus genotype 1 with peginterferon, ribavirin, and epoetin alpha†. Hepatology. 46(2). 371–379. 144 indexed citations

12.

Stravitz, R. Todd, Richard K. Sterling, Velimir A. Luketic, et al.. (2005). Antibody-Mediated Pure Red Cell Aplasia Due to Epoetin Alfa During Antiviral Therapy of Chronic Hepatitis C. The American Journal of Gastroenterology. 100(6). 1415–1419. 37 indexed citations

13.

Price, Angie. (2003). Primary and Secondary Prevention of Colorectal Cancer. Gastroenterology Nursing. 26(2). 73–81. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact